Anti-HSD17B2 Antibody Picoband® 0,00647 Vervoeging

HSD17B2 (17-BETA-HYDROXYSTEROID DEHYDROGENASE II), also called 17-BETA-HSD II, is an anzyme which have 387 amino acids with a predicted molecular weight of 42,782 and associate with the membranes of the endoplasmic reticulum. Its Cytogenetic location is 16q23.3. The type 2 enzyme was capable of catalyzing the interconversion of testosterone and androstenedione, as well as estradiol and estrone. HSD17B2 mRNA was detected in 18 of 42 (43%) adenomas but not in prolactinomas. In the human endometrium, inactivation of 17-beta-estradiol to estrone is catalyzed by HSD17B2. And HSD17B2 activity distinguishing between disease-free and diseased endometria. HSD17B2 efficiently catalyzes the oxidative metabolism of androgens and estrogens, and it is expressed in a large series of human peripheral tissues. The previous paradigm that HSD17B2 activity in the endometrium is elevated during the secretory phase is confined to diseased endometrium but not to disease-free endometrium.

Estradiol 17-beta-dehydrogenase 2;1.1.1.62;17-beta-hydroxysteroid dehydrogenase type 2;17-beta-HSD 2;20 alpha-hydroxysteroid dehydrogenase;20-alpha-HSD; E2DH; Microsomal 17-beta-hydroxysteroid dehydrogenase; Short chain dehydrogenase/reductase family 9C member 2; Testosterone 17-beta-dehydrogenase;1.1.1.239; HSD17B2; EDH17B2, SDR9C2

HSD17B2

3294

P37059

Human

No cross-reactivity with other proteins

A synthetic peptide corresponding to a sequence at the C-terminus of human HSD17B2.

Embryonic nervous system.

Flow Cytometry

Cancer, Growth Factors, Growth Factors/Hormones, Signal Transduction

Immunogen affinity purified.

Liquid

Capable of catalyzing the interconversion of testosterone and androstenedione, as well as estradiol and estrone. Also has 20-alpha-HSD activity. Uses NADH while EDH17B3 uses NADPH.

1. Berube, D., Luu-The, V., Simard, J., Gagne, R., Labrie, F. Localization of the beta-estradiol dehydrogenase genes to q11-q12 of chromosome 17. (Abstract) Cytogenet. Cell Genet. 51: 962 only, 1989. 2. Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., Andersson, S. Male pseudohermaphroditism caused by mutations of testicular 17-beta-hydroxysteroid dehydrogenase 3. Nature Genet. 7: 34-39, 1994. 3. Harkness, R. A., Thistlethwaite, D., Darling, J. A. B., Skakkebaek, N. E., Corker, C. S. Neutral 17-beta-hydroxysteroid oxidoreductase deficiency in testes causing male pseudohermaphroditism in an infant. J. Inherit. Metab. Dis. 2: 51-54, 1979.

At -20 ̊C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

42785 MW

No cross reactivity with other proteins.

6

Estradiol 17-beta-dehydrogenase 2

Membrane ; Single-pass type II membrane protein .

Belongs to the short-chain dehydrogenases/reductases (SDR) family.

Estradiol 17-beta-dehydrogenase 2

Rabbit IgG

Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4, 0.02% NaN3.